MIF and cancer: This paracrine MIF–CD74/CD44 interaction is a well-recognized mechanism of immunosuppression in the TME: MIF is often overexpressed in cancers and can drive macrophages toward an “M2” immunosuppressive, pro-tumoral phenotype (33).